Sat Sep 5 15:43:49 SGT 2015  
SINGAPORE
VACCINE™
    Vaccine, Singapore (SG)

Vaccine, Singapore (SG)

Summary

Vaccine, Singapore (SG) @singaporevaccine_com: vaccine jab/shot/injection schedule, to vaccinate against the infection, to immunise against infectious disease, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Vaccine types available for vaccination / immunisation (uk) / immunization (us) :

Vaccine Against Disease Age D
o
s
e
s
Dose schedule Price
per
dose
(SG$)
Live attenuated
MMR vaccine ≥12m 1 $70/=
Measles virus Measles
Mumps virus Mumps
Rubella virus Rubella
Varilrix™ Varicella zoster virus
HHV-3
Varicella Chickenpox 12m-12y 1 $121/=
≥13y 2 6-10w interval
Zostavax™ Herpes zoster Shingles ≥50y 1 $295/=
Stamaril® Yellow fever virus Yellow fever 9m-59y 1 10 yearly $250/=
Inactivated / Whole / Viral & Bacterial
Rabipur® Rabies virus Rabies any 3 d 0, 7, & 21 or 28 $call/=
Ixiaro® Japanese encephalitis virus Japanese encephalitis ≥17y 2 2nd: 28d after 1st $386/=
1 Booster: 12-24m after 2nd
Dukoral® Vibrio cholerae Cholera 2-6y 3 1-6w interval $113/=
1 Booster: 6m after 3rd
≥6y 2 1-6w interval
1 Booster: 2y after 2nd
Inactivated / Fractional / Protein
Intanza™ Influenza virus Influenza 18-59y 1 1 yearly $30/=
Fluarix™ Influenza virus Influenza 6-36m ½ 1 yearly $30/=
>3y 1
Tetavax Clostridium tetani Tetanus adults 3 1-2m interval
3rd @ 6-12m
after 2nd
$30/=
booster 1 10 yearly
Boostrix® ≥4y 1 <10 yearly $70/=
Corynebacterium diphtheriae Diphtheria
Clostridium tetani Tetanus
Bordetella pertussis Pertussis
Whooping cough
Inactivated / Fractional / Polysaccharide / Pure
Typhim Vi® Salmonella typhi Typhoid fever >5y 1 3 yearly $48/=
Mencevax® ACWY Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis >2y 1 $80/=
Inactivated / Fractional / Polysaccharide / Conjugate
Menactra® Neisseria meningitidis
types A, C, W-135
and Y
Meningococcal meningitis 2-55y 1 $195/=
Prevenar 13® (SG) /
Prevnar 13® (US)
Streptococcus pneumoniae
types 1, 3, 4, 5,
6A, 6B, 7F, 9V, 14,
18C, 19A, 19F, 23F
Pneumococcal infection 6w-6m 4 1m interval
4th @ 12-15m
$274/=
7-11m 2 1m interval
12-23m 2 2m interval
2-5y 1
≥50y 1

If the clinic attendance is just for vaccination alone, no additional consultation fees are charged.

Testing for immunity against the following is available:

Virus Antibody Test Price
Varicella zoster virus Varicella Zoster IgG Antibody $44/=
Measles virus Measles IgG Antibody $90/=
Rubella virus Rubella IgG Antibody $24/=
Hepatitis A virus Hepatitis A IgG Antibody $30/=
Hepatitis B virus Hepatitis B surface Antibody $10/=

Other vaccines not stocked

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: www.shimclinic.com
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

References


Latest News

vaccine.html target=_blank rel="nofollow">Providence will test its new lung cancer vaccine at Mayo, other top clinics
Fri, 04 Sep 2015 20:11:13 +0100 | bizjournals.com Health Care:Biotechnology headlines
Providence Cancer Center has embarked on a new lung cancer vaccine trial encompassing multiple sites around the country, including the Mayo Clinic.

Interchangeability of three recombinant anti-HBV vaccines in primary schedule, irrespective of dose and HBsAg subtype: the first prospective, open-label, randomized study in healthy adult population.
Fri, 04 Sep 2015 19:36:56 +0100 | Polskie Archiwum Medycyny Wewnetrznej
Authors: Rymer W, Zalewska M, Szymczak A, Zubkiewicz-Zarębska A, Knysz B

Antiviral Drugs Targeting Influenza Virus Surface Proteins: A Computational Structural Biology Approach.
Fri, 04 Sep 2015 15:24:02 +0100 | Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
Authors: Igarashi M

Guidelines for the Management of a Pregnant Trauma Patient.
Fri, 04 Sep 2015 13:41:19 +0100 | Journal of Obstetrics and Gynaecology Canada : JOGC
Authors: Jain V, Chari R, Maslovitz S, Farine D, Maternal Fetal Medicine Committee, Bujold E, Gagnon R, Basso M, Bos H, Brown R, Cooper S, Gouin K, McLeod NL, Menticoglou S, Mundle W, Pylypjuk C, Roggensack A, Sanderson F

Cutaneous vaccination - Protective immunization is just a skin-deep step away.
Fri, 04 Sep 2015 05:48:49 +0100 | Vaccine
Authors: Teunissen MB, Zehrung D

Immunotherapy for Multiple Myeloma, Past, Present, and Future: Monoclonal Antibodies, Vaccines, and Cellular Therapies
Fri, 04 Sep 2015 00:00:00 +0100 | Current Hematologic Malignancy Reports
Abstract

The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells
Fri, 04 Sep 2015 00:00:00 +0100 | Microbiological Research
Publication date: Available online 2 September 2015 Source:Microbiological Research Author(s): Shih-Chun Yang, Chi-Feng Hung, Ibrahim A. Aljuffali, Jia-You Fang Shigellosis is an acute invasive enteric infection by the Gram negative pathogen Shigella, which causes human diarrhea. Shigella, which are highly epidemic and pathogenic, have become a serious public health problem. The virulence plasmid is a large plasmid essential to the infected host cells. Many virulence factors are encoded in the ipa-mxi-spa region by the virulence plasmid. IpaB is a multifunctional and essential virulence factor in the infection process. In this review article, we introduce the recent studies of the effect of IpaB in Shigella-infected host cells. IpaB is involved in a type III secretion system (T3SS) s...

Pharmacological therapies in smoking cessation: an evidence-based update
Fri, 04 Sep 2015 00:00:00 +0100 | Current Respiratory Care Reports
Abstract

Quantifying and explaining accessibility with application to the 2009 H1N1 vaccination campaign
Fri, 04 Sep 2015 00:00:00 +0100 | Health Care Management Science
Abstract

High-Resolution Spatial Analysis of Cholera Patients Reported in Artibonite Department, Haiti in 2010-2011
Fri, 04 Sep 2015 00:00:00 +0100 | Epidemics
Conclusion/significance These findings demonstrate the value of high-resolution mapping for pinpointing locations most affected by cholera, and in the future could help prioritize the places in need of interventions such as improvement of sanitation and vaccination. The findings also describe spatio-temporal transmission patterns of the epidemic in a cholera-naïve country such as Haiti. By identifying transmission hubs, it is possible to target prevention strategies that, over time, could reduce transmission of the disease and eventually eliminate cholera in Haiti. (Source: Epidemics)